B
BioTrace Medical
BioTrace Medical, Inc is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs
About BioTrace Medical
BioTrace Medical Inc. specializes in the development and commercialization of advanced temporary cardiac pacing leads. The company's flagship product, the Tempo Lead, is the only active fixation temporary pacing lead available in the United States, designed to improve patient outcomes during cardiac procedures. BioTrace Medical serves healthcare providers, including hospitals and cardiology clinics, operating within the medical device market. The business model revolves around the sale of its proprietary medical devices to these institutions, generating revenue through direct sales and distribution partnerships. The company is headquartered in Menlo Park, California, and is committed to innovation and excellence in cardiac care.
Source: Dealroom company dataAt a glance
- Founded
- 2013
- Headquarters
- Menlo Park, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Life Sciences Angel Network
Okapi Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioTrace Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioTrace Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.